Brief: Adagene Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
09/05/2025 21:41
Adagene Inc 978y.F: ADAGENE INC FILES FOR MIXED SHELF OF UP TO $200 MILLION - SEC FILING Source text: [ID:n0001104659-25-046772] Further company coverage: [978y.F]
Recent news on Adagene
See all newsBrief: Adagene To Begin Phase 1 Study Of ADG138 For Advanced Solid Tumors In Q4 2026
Brief: Adagene Announces That Third Arc Bio Has Selected First Lead Candidate Under Amended Strategic Collaboration For Development Of Masked Cd3 T Cell Engagers Utilizing Safebody® Technology
Brief: Adagene Inc Announces Offering Of American Depositary Shares
Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate